rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
ALEMBIC PHARMACEUTICALS LTD. - Statement Regarding Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended 30Th September, 2017
Download announcement < Back
07 Oct 2017
With reference to the captioned subject, we enclose herewith Statement regarding investor complaints as per Regulation 13(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter ended 30th September, 2017.&lt;BR&gt; &lt;BR&gt; We request you to kindly take the same on record.
View all announcements for ALEMBIC PHARMACEUTICALS LTD. Source: BSE India